The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2
Abstract
The transient receptor potential (TRP) vanilloid subtype 4 (V4) is a nonselective cation channel that exhibits polymodal activation and is expressed in the endothelium, where it contributes to intracellular Ca2+ homeostasis and regulation of cell volume. The purpose of the present study was to evaluate the systemic cardiovascular effects of GSK1016790A, a novel TRPV4 activator, and to examine its mechanism of action. In three species (mouse, rat, and dog), the i.v. administration of GSK1016790A induced a dose-dependent reduction in blood pressure, followed by profound circulatory collapse. In contrast, GSK1016790A had no acute cardiovascular effects in the TRPV4-/- null mouse. Hemodynamic analyses in the dog and rat demonstrate a profound reduction in cardiac output. However, GSK1016790A had no effect on rate or contractility in the isolated, buffer-perfused rat heart, and it produced potent endothelial-dependent relaxation of rodent-isolated vascular ring segments that were abolished by nitric-oxide synthase (NOS) inhibition (N-nitro-L-arginine methyl ester; L-NAME), ruthenium red, and endothelial NOS (eNOS) gene deletion. However, the in vivo circulatory collapse was not altered by NOS inhibition (L-NAME) or eNOS gene deletion but was associated with (concentration and time appropriate) profound vascular leakage and tissue hemorrhage in the lung, intestine, and kidney. TRPV4 immunoreactivity was localized in the endothelium and epithelium in the affected organs. GSK1016790A potently induced rapid electrophysiological and morphological changes (retraction/condensation) in cultured endothelial cells. In summary, inappropriate activation of TRPV4 produces acute circulatory collapse associated with endothelial activation/injury and failure of the pulmonary microvascular permeability barrier. It will be important to determine the role of TRPV4 in disorders associated with edema and microvascular congestion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HUVECs may not entirely recapitulate all known roles for TRPV4 in tumor vasculature. 24,28,35,51,53,66”
From Rapid Assessment of Nanoparticle Extravasation in a Microfluidic Tumor Model (2019) · cites this paper as [24]
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Liedtke, W., Choe, Y., Martı́-Renom, M. A., Bell, A. M., Denis, C. S., AndrejŠali, Hudspeth, A. J., Friedman, J. M., & Heller, S. (2000) · Cell · doi:10.1016/s0092-8674(00)00143-4 · Cited by 1,391
Cellular regulation of endothelial nitric oxide synthase
Govers, R., & Rabelink, T. J. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f193 · Cited by 476
TRPV4 Forms a Novel Ca 2+ Signaling Complex With Ryanodine Receptors and BK Ca Channels
Earley, S., Heppner, T. J., Nelson, M. T., & Brayden, J. E. (2005) · Circulation Research · doi:10.1161/01.res.0000194321.60300.d6 · Cited by 448
Yue, T., Wang, C., Gu, J.-L., Ma, X., Kumar, S., Lee, J. C., Feuerstein, G., Thomas, H. C., Maleeff, B. E., & Ohlstein, E. H. (2000) · Circulation Research · doi:10.1161/01.res.86.6.692 · Cited by 421
Self-citationTransient Receptor Potential Channels in Cardiovascular Function and Disease
Inoue, R., Jensen, L. J., Shi, J., Morita, H., Nishida, M., Honda, A., & Ito, Y. (2006) · Circulation Research · doi:10.1161/01.res.0000233356.10630.8a · Cited by 368
Köhler, R., Heyken, W., Heinau, P., Schubert, R., Si, H., Kacik, M., Busch, C., Grgic, I., Maier, T., & Hoyer, J. D. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000225698.36212.6a · Cited by 346
Transient Receptor Potential Vanilloid 4–Mediated Disruption of the Alveolar Septal Barrier
Alvarez, D. F., KING, J. A. C., Weber, D. S., Addison, E., Liedtke, W., & Townsley, M. I. (2006) · Circulation Research · doi:10.1161/01.res.0000247065.11756.19 · Cited by 311
Yang, X.-R., Lin, M., McIntosh, L. S., & Sham, J. S. K. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00515.2005 · Cited by 278
Self-citationRecent Developments in Vascular Endothelial Cell Transient Receptor Potential Channels
Yao, X., & Garland, C. J. (2005) · Circulation Research · doi:10.1161/01.res.0000187473.85419.3e · Cited by 276
Cited by
Sorted by citations
Items 201–300 of 307
Small Molecule Agonists and Antagonists of TRPV4
Duncton, M. A. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420024-1.00012-6 · Cited by 10
Petrova, R. S., Nair, N., Bavana, N., Chen, Y., Schey, K. L., & Donaldson, P. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109080 · Cited by 10
Liu, G., Liu, J., Kong, X., Xiong, W., & Jiang, R. (2023) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdad093 · Cited by 10
Endothelial Ca2+ signaling-dependent vasodilation through transient receptor potential channels
Hong, K., & Lee, M.-G. (2020) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2020.24.4.287 · Cited by 10
Consideration of Kinase Inhibitors for the Treatment of Hydrocephalus
Blazer‐Yost, B. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076673 · Cited by 9
Dryn, D. O., Melnyk, M. I., Melanaphy, D., Kizub, I. V., Johnson, C. D., & Zholos, A. V. (2023) · Biomolecules · doi:10.3390/biom13050759 · Cited by 9
Regulation of cardiovascular TRP channel functions along the NO–cGMP–PKG axis
Inoue, R., Shi, J., Zhong, J., & Imai, Y. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.15 · Cited by 9
Zubcevic, L. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15310 · Cited by 9
Kanthakumar, P., & Adebiyi, A. (2021) · Current Research in Physiology · doi:10.1016/j.crphys.2021.02.001 · Cited by 9
de Oliveira, J. R. J. M., Amorim, M. A., & Andrè, E. (2020) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.102004 · Cited by 8
Transient Receptor Potential Vanilloid 4: a Double-Edged Sword in the Central Nervous System
Zeng, M., Kong, S., Chen, T.-X., & Peng, B. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03141-6 · Cited by 9
TRPs: Modulation by Drug-Like Compounds
Schaefer, M. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-05161-1_15 · Cited by 8
Permeability and calcium signaling in lung endothelium: unpack the box…
Townsley, M. I. (2017) · Pulmonary Circulation · doi:10.1177/2045893217738218 · Cited by 8
Ponce, A., Larré, I., Jimenez, L., Roldán, M. L., Shoshani, L., & Cereijido, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316687 · Cited by 7
Li, Q., Kresge, C. K., Boggs, K., Scott, J. A., & Feranchak, A. P. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00176.2019 · Cited by 7
The Calcium Signalling Profile of the Inner Blood–Retinal Barrier in Diabetic Retinopathy
Moccia, F. D., & Dragoni, S. (2025) · Cells · doi:10.3390/cells14120856 · Cited by 10
Langan, S. P., Casa, D. J., & Kwon, O. S. (2025) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2025.104331 · Cited by 6
Potential Role of TRPV4 in Stretch-Induced Ghrelin Secretion and Obesity
Hayakawa, S., Tanaka, T., Ogawa, R., Ito, S., Ueno, S., Koyama, H., Okubo, T., Sagawa, H., Tanaka, T., Iwakura, H., et al. (2022) · International Journal of Endocrinology · doi:10.1155/2022/7241275 · Cited by 6
TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate
Meng, M. Y., Paine, L. W., Sagnat, D., Bello, I., Oldroyd, S., Javid, F. A., Harper, M. T., Hockley, J. R. F., Smith, E. S. J., Owens, R. M., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17408 · Cited by 6
Advances in the Study for Modulators of Transient Receptor Potential Vanilloid (TRPV) Channel Family
Wang, Y., Shi, Y., Zuo, M., Yu, Y., & Huang, X. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266294569241115053420 · Cited by 6
Evaluation of GSK2789917-induced TRPV4 inhibition in animal models of fluid induced lung injury
Bihari, S., Costell, M. H., Bouchier, T., Behm, D. J., Burgert, M. E., Ye, G., Bersten, A. D., Puukila, S., Cavallaro, E. C., Sprecher, D. L., et al. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02821-x · Cited by 6
Self-citationA TRP to Pathological Angiogenesis and Vascular Normalization
Katari, V., Dalal, K. K., Adapala, R. K., Guarino, B. D., Kondapalli, N. B., Paruchuri, S. M., & Thodeti, C. K. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230014 · Cited by 11
Physiological functions and pharmacological targeting of transient receptor potential channels
Chubanov, V., Grimm, C. M., Hill, K., Schaefer, M., Köttgen, M., Storch, U., y Schnitzler, M. M., Kudrina, V., Erbacher, A., & Gudermann, T. W. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100089 · Cited by 8
Discovery of a novel orally active TRPV4 inhibitor: Part 1. Optimization from an HTS hit
Sami, Y., Morita, M., Kubota, H., Hirabayashi, R., Seo, R., & Nakagawa, N. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.05.041 · Cited by 5
Pacheco, G., de Oliveira, A. P., Nolêto, I. R. D. S. G., Araujo, A. K. S., Lopes, A. L. F., Sousa, F. B. M., Chaves, L. S., Alves, E. H. P., Vasconcelos, D. F. P., de Araújo, A. R., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174113 · Cited by 5
Weerts, Z. Z. R. M. (2021) · doi:10.26481/dis.20211015zw · Cited by 5
Dong, Q., Wang, Z., Wu, Q., & Du, Y. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118765 · Cited by 4
Zhang, L., Xu, Y., Ma, Y., Xie, T., Liu, C., & Liu, Q. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1071198 · Cited by 4
Wang, H., Meng, X., Chen, M., Xu, S., Zhu, M., Lu, X. J., Wu, F., & Yu, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.151 · Cited by 4
Endothelial Cell Calcium Influx Mediates Trauma-induced Endothelial Permeability
Schaid, T. R., Mitra, S., Stafford, P., DeBot, M., Thielen, O. N., Hallas, W. M., Cralley, A. L., Gallagher, L. T., Jeffrey, D. A., Hansen, K. C., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000006164 · Cited by 4
Transient Receptor Potential channels (TRP) in GtoPdb v.2023.3
Blair, N. T., Caceres, A. I., Carvacho, I., Chaudhuri, D., Clapham, D. E., Clercq, K. D., Delling, M., Doerner, J. F., Fan, L., Grimm, C. M., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f78/2023.3 · Cited by 4
Pairet, N., Mang, S., Kiechle, T., Laufhäger, N., Dietl, P., & Lamb, D. J. (2019) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2019.100672 · Cited by 4
Transient Receptor Potential Cation Channel Subfamily V Member 4 (TRPV4)
Redmon, S. N., Shibasaki, K., & Križaj, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101977 · Cited by 6
Dragoni, S., Moccia, F., & Bootman, M. D. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041763 · Cited by 6
Wu, X., Liu, S., Zhao, Q. P., Xu, M., Jia, C., Shi, J., Yu, J., & Dong, S. (2026) · Inflammation · doi:10.1007/s10753-025-02433-y · Cited by 3
Xu, X., Goyal, N., Costell, M. H., Roethke, T. J., James, C. H., Thorneloe, K. S., Patterson, J. K., Stoy, P., Goodman, K. B., Sprecher, D. L., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000307 · Cited by 3
Self-citationHu, F., Cao, X., Niu, C., & Wang, K. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.121.000370 · Cited by 3
Transient Receptor Potential channels (TRP) in GtoPdb v.2023.1
Blair, N. T., Carvacho, I., Chaudhuri, D., Clapham, D. E., Clercq, K. D., Delling, M., Doerner, J. F., Fan, L., Grimm, C. M., Ha, K., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f78/2023.1 · Cited by 3
Chinigò, G., Ruffinatti, F. A., & Munaron, L. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189226 · Cited by 3
TRP-Mediated Cytoskeletal Reorganization: Implications for Disease and Drug Development
Goswami, C. (2012) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-077-9_2 · Cited by 3
Armando, I., & José, P. A. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.125310 · Cited by 3
Kuebler, W. M., Jordt, S., & Liedtke, W. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3558887 · Cited by 3
Chen, Y., Webb, K. F., & Donaldson, P. J. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.15.37 · Cited by 2
TRPV4, a Regulatory Channel in the Production of Cerebrospinal Fluid by the Choroid Plexus
Hochstetler, A., Reed, M., & Blazer‐Yost, B. L. (2020) · Physiology in health and disease · doi:10.1007/978-1-0716-0536-3_7 · Cited by 2
Шемарова, И. В. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115682 · Cited by 2
The Molecular Mechanism of Multifunctional Mechano-Gated Channel TRPV4
Suzuki, M., & Mizuno, A. (2012) · Springer eBooks · doi:10.1007/978-94-007-5073-9_4 · Cited by 2
Cain, C. T. C. (2010) · Science-Business eXchange · doi:10.1038/scibx.2010.1311 · Cited by 2
Following Ussing’s legacy: from amphibian models to mammalian kidney and brain
Blazer‐Yost, B. L. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00303.2022 · Cited by 2
Control of TRPV4 and Its Effect on the Lung
Parker, J. C., & Townsley, M. I. (2010) · Springer eBooks · doi:10.1007/978-90-481-9881-8_10 · Cited by 2
Zhu, Y., & Pei, Z. (2018) · Cellular and Molecular Biology · doi:10.14715/cmb/2018.64.7.14 · Cited by 2
Transient Receptor Potential channels (TRP) in GtoPdb v.2021.3
Blair, N. T., Carvacho, I., Chaudhuri, D., Clapham, D. E., DeCaen, P. G., Delling, M., Doerner, J. F., Fan, L., Ha, K., Jordt, S. E., et al. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f78/2021.3 · Cited by 2
Transient Receptor Potential Cation Channel Subfamily V Member 4 (TRPV4)
Redmon, S. N., Shibasaki, K., & Križaj, D. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101977-1 · Cited by 4
Phosphorylation on TRPV4 Serine Residue 824 Enhances Its Association with PGM1
Shin, S. H., Lee, E. J., Hyun, S. H., & Kang, S. S. (2016) · American Journal of Molecular Biology · doi:10.4236/ajmb.2016.61004 · Cited by 1
Lyu, B., Lin, J., Chen, L., & Wang, Y. (2026) · Cell Calcium · doi:10.1016/j.ceca.2026.103108 · Cited by 1
Small molecule inhibition rescues the skeletal dysplasia phenotype of Trpv4 mutant mice
Nevarez, L., Ismaili, T., Zieba, J. T., Martin, J. H., Wachtell, D., Diaz, D., Ramirez, J., Aceves, V., Ito, J. M., Gray, R. S., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.182439 · Cited by 1
TRP channels as drug targets: Structural insights and therapeutic relevance
Boda, V. K., & Li, W. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00083-2 · Cited by 1
Müller, I., Alt, P., Gudermann, T. W., Kiefmann, M., & Dietrich, A. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04475-z · Cited by 1
Inoue, R., Hu, Y., Duan, Y., & Itsuki, K. (2012) · Springer eBooks · doi:10.1007/978-94-007-5073-9_10 · Cited by 1
Martz, L. (2012) · Science-Business eXchange · doi:10.1038/scibx.2012.1251 · Cited by 1
Turner, G. H., & Bao, W. (2015) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000366 · Cited by 1
Self-citationTRPV1 Antagonism: From Research to Clinic
Nash, M. S., Verkuyl, J. M., & Bhalay, G. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735087-00186 · Cited by 1
Vincent, F., & Duncton, M. A. J. (2012) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-077-9_13 · Cited by 1
Una luz frente a la pérdida de visión por diabetes
Universidad Nacional Autónoma de México (UNAM), I. D. N., & Thébault, S. C. (2018) · Revista Digital Universitaria · doi:10.22201/codeic.16076079e.2018.v19n5.a3 · Cited by 1
TRP Channels in the Sensation of Heat
Tan, C., & McNaughton, P. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-18705-1_8 · Cited by 1
TRP Channels, Oxidative Stress and Chronic Obstructive Pulmonary Disease
Mandal, A., Srivastava, A., Chakraborti, T., & Chakraborti, S. (2019) · Springer eBooks · doi:10.1007/978-981-32-9366-3_10 · Cited by 1
Re: Sun-Kui Ke et al. TRiPping over vasotonus regulation in the lung
Gollasch, M., & Kuebler, W. M. (2015) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2015.10.007 · Cited by 1
James, C. H. (2014) · Surrey Research Insight Open Access (The University of Surrey) · Cited by 1
Dysfunction of Ca2+ Channels in Hereditary and Chronic Cardiovascular DiseasesPreprint
Шемарова, И. В. (2023) · Preprints.org · doi:10.20944/preprints202305.1947.v1 · Cited by 1
Liedtke, W. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5118371 · Cited by 1
Role of TRP Channels in Pain: An Overview
SZALLASI, A. (2010) · doi:10.1002/9780470588284.ch2
TRP Channels and Human Diseases
Nilius, B., & Vennekens, R. (2010) · Wiley eBooks · doi:10.1002/9780470588284.ch1
高山, 靖., タカヤマ, ヤ., & Takayama, Y. (2013) · SOKENDAI (Graduate University for Advanced Studies)
Li, Y. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
TRP Expression and Function in the Lung Airways
Dietrich, A., & Gudermann, T. W. (2012) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-077-9_14
Function and Oxygen Saturation in Chemically Induced Acute Lung Injury
Balakrishna, S., Song, W., Achanta, S., Doran, S. F., Liu, B., Kaelberer, M. M., Yu, Z., Sui, A., Cheung, M., Bradshaw, H. B., et al. (2014)
Calcium signalling modifying proteins as targets for breast cancer therapy
Jamaludin, S. Y. N. (2014) · The University of Queensland · doi:10.14264/uql.2015.168
Wissenbach, U. (2013) · Springer eBooks · doi:10.1007/978-3-642-40282-1_27
Novel pharmacotherapies for heart failure
Rajapreyar, I. N., Lenneman, A., & Prabhu, S. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813706-2.00018-x
Qiu, L., Du, L., Liang, Q., Hu, H., & Tu, Z. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127573
(2017) · Frontiers in neuroscience · doi:10.1201/9781315152837-10
Transient Receptor Potential channels (TRP) in GtoPdb v.2022.1
Blair, N. T., Carvacho, I., Chaudhuri, D., Clapham, D. E., DeCaen, P. G., Delling, M., Doerner, J. F., Fan, L., Grimm, C. M., Ha, K., et al. (2022) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f78/2022.1
Robertson, D., & Mai, T. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717957871.793462173
TRPV4 Specific Inhibition Ameliorates Fluid-Induced Lung InjuryPreprint
Bihari, S., Costell, M. H., Bouchier, T., Behm, D. J., Burgert, M. E., Ye, G., Bersten, A. D., Puukila, S., Cavallaro, E. C., Sprecher, D. L., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4110953
Self-citationPang, J. (2024) · Physiology · doi:10.5772/intechopen.114957
Blazer‐Yost, B. L., & Halm, D. R. (2025) · Current human cell research and applications · doi:10.1007/978-981-97-9495-9_5
Potential Therapeutic Applications for TRPV4 Antagonists in Lung Disease
Townsley, M. I., & Parker, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420024-1.00013-8
Rôle du signal calcique dans l'inflammation vasculaire : SERCA3 & TRPV4
Beddek, K. (2022) · theses.fr (ABES) · doi:10.70675/f958b707ze1c2z41c7z9314z2d941dac268d
TRP channels functional role in prostate cancer angiogenesis and invasion
Chinigò, G. (2022) · theses.fr (ABES) · doi:10.70675/d329cfb4zc018z4dbbz94e1zd44bbaefe49b
Girard, B. M., Vadnal, L., McCaffrey, B. F. S., Campbell, S. E., & Vizzard, M. A. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02547-4
25+ Years of TRPV4: From Discovery to Translational HorizonsPreprint
Liedtke, W. (2026) · Research Square · doi:10.21203/rs.3.rs-10022857/v1
Upadhyay, S., & Sharma, S. S. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2691873
TRPV4: A Promising Therapeutic Target Ion Channel─Discovery of Ultrapotent Selective Antagonists
Nilsson, M., Bonvini, S. J., Diers, E., Johansson, J., Lawrence, N., Andersson, H., von Berg, S., Berglund, S., Birrell, M. A., Bold, P., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00672
Shima, Y., & Watanabe, A. (2026) · Sclerosis · doi:10.3390/sclerosis4030019
Chen, Y., & Donaldson, P. J. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.8.60
Manukyan, A. S., & Григорьевна, П. А. (2026) · Bulletin physiology and pathology of respiration · doi:10.36604/1998-5029-2026-101-72-83
BindingDB (2021) · UC San Diego · doi:10.7270/q2hd803s
BindingDB (2013) · UC San Diego · doi:10.7270/q2vt1tdb
Metadata
- Authors
- Willette, R. N., Bao, W., Nerurkar, S., Yue, T.-L., Doe, C. P., Stankus, G., Turner, G. H., Ju, H., Thomas, H., Fishman, C. E., Sulpizio, A., Behm, D. J., Hoffman, S., Lin, Z., Lozinskaya, I., Casillas, L. N., Lin, M., Lee Trout, R. E., Votta, B. J., Thorneloe, K., Lashinger, E. S. R., Figueroa, D. J., Marquis, R., & Xu, X.
- Affiliations
- GlaxoSmithKline (United States) (US)
- ORCID
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 326
- Issue
- 2
- Pages
- 443-452
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2161804336
- Cited by
- 300
- References
- 21
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 8 · 2023: 20 · 2022: 16 · 2021: 14 · 2020: 24 · 2019: 21 · 2018: 16 · 2017: 22 · 2016: 17 · 2015: 19 · 2014: 22 · 2013: 14 · 2012: 20
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2011-07-01)
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- TRPV4, GSK1016790A, cardiovascular collapse, endothelial permeability, endothelial injury, endothelial cell retraction, nitric oxide synthase, endothelium-dependent relaxation, blood pressure reduction, cardiac output, TRPV4 knockout mice, edema
- MeSH terms
- Animals, Aorta, Thoracic, Capillary Permeability, Cell Adhesion, Cell Line, Dogs, Dose-Response Relationship, Drug, Endothelium, Vascular, Female, Hemodynamics, Humans, Immunohistochemistry, Leucine, Male, Sulfonamides, Vasoconstriction, Molecular Structure, Ventricular Function, Left, Rats, Sprague-Dawley, Mice, Knockout, Patch-Clamp Techniques, TRPV Cation Channels, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review